Race Oncology Ltd Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

Race Oncology Ltd capital reinvestment ratio. Race Oncology Ltd (RAC) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (AU$570.64K) in capital expenditures (AU$4.00). Check Race Oncology Ltd (RAC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$570.64K
AUD

Capital Expenditures

AU$4.00
AUD

Data as of

Dec 2024
Most recent filing

Capital Reinvestment Ratio of Race Oncology Ltd (2011–2013)

Capital reinvestment ratio of Race Oncology Ltd from 2011 to 2013. This chart tracks Race Oncology Ltd's Capital Reinvestment Ratio across 3 annual periods. Also explore Race Oncology Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Race Oncology Ltd Capital Reinvestment Ratio by Year (2011–2013)

Race Oncology Ltd capital reinvestment ratio by year from 2011 to 2013. For the full cash flow conversion analysis, see Race Oncology Ltd cash conversion from operations.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2013 0.01x AU$3.71 Million AU$31.00K ▼ -74.4%
2012 0.03x AU$6.68 Million AU$218.00K ▲ +439.7%
2011 0.01x AU$11.92 Million AU$72.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow